Factors Affecting Bisphosphonate Therapy Compliance In Patients With Osteogenesis Imperfecta
| Autor: | Firdaus Ramli F, Wendy Yolanda Rossa, Naufal Chairulfatah, Doddi Putra Pratama Sudjana, Yoyos Dias Ismiarto |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
National health
Pediatrics medicine.medical_specialty business.industry medicine.medical_treatment osteogenesis imperfecta bisphosphonate compliance lcsh:RM1-950 Disease Bisphosphonate medicine.disease lcsh:RC346-429 Compliance (physiology) Health services lcsh:Therapeutics. Pharmacology Osteogenesis imperfecta medicine In patient Bisphosphonate therapy business lcsh:Neurology. Diseases of the nervous system |
| Zdroj: | Bioscientia Medicina: Journal of Biomedicine and Translational Research, Vol 4, Iss 4, Pp 55-59 (2020) |
| ISSN: | 2598-0580 |
| Popis: | BACKGROUND: Osteogenesis imperfecta (OI) is a genetic disease with clinical manifestations in patients' bones. This study aims to investigate the factors that influence the compliance of bisphosphonate in patients with OI. METHODS: A cross-sectional analysis method was conducted and data were obtained from questionnaires answered by OI patients that received bisphosphonate. The data obtained were statistically analyzed using chi-square. RESULTS: There were 121 OI patients, age range 0-5 years (62%). Almost all patients have insurance from national health (BPJS). In this study, the average treatment compliance was 81.7%, and patients were reported to have good medication compliance of ≥80% of the treatment cycle, which was shown in 65 patients (53.7%). However, there is a relationship between parent education and treatment compliance (P = 0.046). DISCUSSION: It is a measurement of behavior related to treatment recommendations by medical professionals. On the contrary, the level of non-compliance patients with chronic disease to treatment is quite high. CONCLUSION: Good treatment compliance describes when the patient performs ≥80% of its cycle. Factors affecting it are the condition of the patient and the location of health services. Therefore, there is a relationship between compliance with the number of treatment cycles. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|